Cargando…

Deviation from baseline mutation burden provides powerful and robust rare-variants association test for complex diseases

Identifying rare variants that contribute to complex diseases is challenging because of the low statistical power in current tests comparing cases with controls. Here, we propose a novel and powerful rare variants association test based on the deviation of the observed mutation burden of a gene in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lin, Jiang, Hui, Dai, Sheng, Chen, Ying, Song, Youqiang, Tang, Clara Sze-Man, Pang, Shirley Yin-Yu, Ho, Shu-Leong, Wang, Binbin, Garcia-Barcelo, Maria-Mercedes, Tam, Paul Kwong-Hang, Cherny, Stacey S, Li, Mulin Jun, Sham, Pak Chung, Li, Miaoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989543/
https://www.ncbi.nlm.nih.gov/pubmed/34931221
http://dx.doi.org/10.1093/nar/gkab1234
Descripción
Sumario:Identifying rare variants that contribute to complex diseases is challenging because of the low statistical power in current tests comparing cases with controls. Here, we propose a novel and powerful rare variants association test based on the deviation of the observed mutation burden of a gene in cases from a baseline predicted by a weighted recursive truncated negative-binomial regression (RUNNER) on genomic features available from public data. Simulation studies show that RUNNER is substantially more powerful than state-of-the-art rare variant association tests and has reasonable type 1 error rates even for stratified populations or in small samples. Applied to real case-control data, RUNNER recapitulates known genes of Hirschsprung disease and Alzheimer's disease missed by current methods and detects promising new candidate genes for both disorders. In a case-only study, RUNNER successfully detected a known causal gene of amyotrophic lateral sclerosis. The present study provides a powerful and robust method to identify susceptibility genes with rare risk variants for complex diseases.